Shree Anand Life Sciences

What Shree Anand Life Sciences does

Shree Anand Life Sciences Ltd (SALSL) is a privately held, Belagavi (Karnataka, India)-based pharmaceutical manufacturer specializing in sterile Small Volume Parenteral (SVP) injectable formulations. The company was established by the promoters of Anand Pharmaceuticals, a formulation unit operating in North Karnataka since 1989, and commissioned its modern cGMP-compliant manufacturing facility at Plot No 63 A & B, Honaga Industrial Area in or around 2021. SALSL produces liquid injections (in ampoules, vials, and pre-filled syringes), dry powdered injections, and lyophilized injections across therapeutic categories including anticoagulants (Enoxaparin), proton pump inhibitors (Rabeprazole Sodium), neuromuscular blockers (Atracurium Besylate, Cisatracurium), NSAIDs (Diclofenac), corticosteroids (Dexamethasone, Hydrocortisone), antimalarials (Artesunate 60mg/120mg), and antifungals (Amphotericin-B). The Belagavi site holds WHO GMP, GMP, GLP, and ISO 9001:2015 accreditations and is operated under the leadership of Satish M Gharge (Chairman & Managing Director), who has been in pharmaceutical manufacturing since 1987.

The company's underlying technology platform is a single-site aseptic manufacturing stack rather than a software platform. The 2-acre Belagavi plant is configured with Class C processing areas and Class A/B filtration and filling zones, ISO-5 to ISO-8 cleanrooms served by 27 air handling units, 13 exhaust systems, and 10 ventilation units with terminal HEPA filtration at 99.997% efficiency. Utilities are produced in-house: a Multi Effect Distillation Still produces Water for Injection (WFI) stored in SS 316L tanks at above 80°C, and on-site nitrogen is generated at 99.99% purity at 10 m³/hour. Production equipment includes CIP/SIP vessels, washing machines, sterilizing tunnels, lyophilizers, pre-filled syringe filling machines, and an automatic 100% visual inspection machine; QC is GLP- and 21 CFR-compliant with UV/VIS, FTIR, TOC, HPLC, GC, and analytical balances.

SALSL's business model is B2B contract-manufacturing of sterile injectables, selling to domestic Indian pharmaceutical buyers and export-market clients, with pricing conducted on a quote basis (no public pricing, no disclosed license economics). The company is privately held, has no external funding rounds or institutional investors on record, and operates with a headcount in the 51–100 range. Distribution is direct to enterprise pharma buyers; social channels (LinkedIn, Facebook, YouTube) are used only for top-of-funnel visibility.

Name

Shree Anand Life Sciences

Legal name

Shree Anand Life Sciences Ltd

Website

https://salsl.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Shree Anand Life Sciences Ltd is a Belagavi-based, privately held pharmaceutical manufacturer of sterile Small Volume Parenteral (SVP) injectable formulations — liquid, dry powder, lyophilized, and pre-filled syringe products — sold on a B2B basis to domestic and export pharmaceutical buyers.

Ownership category

akta.pro rank

Product category

Sterile Injectable Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIABAL

Generic Hospital & Institutional Products

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAIACAO

Specialty Injectable & Infusion Therapies (Cross-therapeutic)

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

Keywords

• Sterile injectable manufacturing
• Small volume parenterals
• Lyophilized injection production
• Prefilled syringe manufacturing
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Belgami

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Injectable Formulations: B2B sale of sterile injectable pharmaceutical products including liquid injections (ampoules, vials, pre-filled syringes), dry powdered injections, and lyophilized injections to domestic and export markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Shree Anand Life Sciences Limited manufactures and sells Small Volume Parenteral (SVP) sterile injectable pharmaceutical formulations under cGMP conditions. Its product range spans liquid injections in ampoules, vials, and pre-filled syringes, dry powdered injections, and lyophilized injections, covering therapeutic categories including anticoagulants, proton pump inhibitors, neuromuscular blocking agents, NSAIDs, corticosteroids, antimalarials, and antifungals for B2B customers in domestic and export markets.

Product overview

Shree Anand Life Sciences Ltd operates as a pharmaceutical manufacturer specializing in Small Volume Parenteral (SVP) injectable formulations. The company produces a portfolio of sterile injectable products across four main categories: Liquid Injections (manufactured in ampoules, vials, and pre-filled syringes), Dry Powdered Injections, and Lyophilized Injections. The product portfolio includes therapeutic categories such as anticoagulants (Enoxaparin), proton pump inhibitors (Rabeprazole Sodium), neuromuscular blocking agents (Atracurium Besylate, Cisatracurium), NSAIDs (Diclofenac), corticosteroids (Dexamethasone, Hydrocortisone), antimalarials (Artesunate), and antifungals (Amphotericin-B). The company manufactures all products under cGMP conditions with capabilities including CIP/SIP vessels, washing machines, sterilizing tunnels, filling machines, lyophilizers, and pre-filled filling machines, with processing conducted in Class C environments and filtration/filling in Class A/B areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Liquid Injections Sterile liquid injectable formulations manufactured in ampoules, vials, and pre-filled syringes for therapeutic delivery to pharmaceutical companies and healthcare providers in domestic and export markets.
• Dry Powdered Injections Sterile injectable formulations in dry powder form requiring reconstitution prior to administration, supplied to pharmaceutical companies and healthcare providers.
• Lyophilized Injections Freeze-dried sterile injectable products designed for enhanced stability and extended shelf life, supplied to pharmaceutical companies and healthcare providers.
• Enoxaparin Injection 60mg Anticoagulant (blood thinner) delivered in sterile pre-filled syringes, used to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), including during pregnancy and following certain types of surgery.
• Rabeprazole Sodium 20mg Proton pump inhibitor injectable formulation for reducing stomach acid production, supplied to pharmaceutical companies and healthcare providers.
• Atracurium Besylate Injection Neuromuscular blocking agent injectable formulation used as an anesthesia adjunct for surgical procedures, supplied to pharmaceutical companies and healthcare providers.
• Diclofenac 75mg Non-steroidal anti-inflammatory drug (NSAID) injectable formulation for pain and inflammation management, supplied to pharmaceutical companies and healthcare providers.
• Cisatracurium Neuromuscular blocking agent injectable formulation, supplied to pharmaceutical companies and healthcare providers for surgical and critical care use.
• Dexamethasone Corticosteroid injectable formulation for anti-inflammatory and immunosuppressive applications, supplied to pharmaceutical companies and healthcare providers.
• Hydrocortisone Corticosteroid injectable formulation for anti-inflammatory applications, supplied to pharmaceutical companies and healthcare providers.
• Artesunate 120mg Antimalarial injectable formulation at 120mg strength for treating severe malaria, supplied to pharmaceutical companies and healthcare providers.
• Artesunate 60mg Antimalarial injectable formulation at 60mg strength for treating severe malaria, supplied to pharmaceutical companies and healthcare providers.
• Amphotericin-B Antifungal injectable formulation for treating serious systemic fungal infections, supplied to pharmaceutical companies and healthcare providers.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Anand PharmaceuticalscoreOthersPromoters of SALSL are partners in Anand Pharmaceuticals, a formulation unit based in North Karnataka established in 1989. Anand Pharmaceuticals successfully set up a Small Volume Parenteral (SVP) injectable formulations plant at Mudhol, Karnataka, providing the foundation and expertise for SALSL's operations.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Themis Medicare: Themis Medicare is an Indian pharmaceutical company with a focused sterile injectable portfolio covering anesthetics, analgesics, and critical care injectables. Its product overlap (Atracurium, Diclofenac family) and small-volume parenteral format make it a closely comparable mid-sized Indian injectable manufacturer.
• Gland Pharma: Gland Pharma is one of India's largest sterile injectable manufacturers with a portfolio spanning liquid injectables, lyophilized products, and pre-filled syringes, exporting globally including to the US. It is directly comparable to SALSL in SVP format mix and export-led growth, but at substantially larger scale (acquired by Fosun in 2022).
• Neon Laboratories: Neon Laboratories is an Indian manufacturer focused on sterile injectables including neuromuscular blockers, anesthetics, and critical care injectables. Its product overlap with SALSL molecules (Atracurium, Diclofenac, Dexamethasone) and small-volume parenteral focus make it a directly comparable Indian injectable specialist.
• Bharat Serums and Vaccines: Bharat Serums and Vaccines (BSV) is an India-based specialty injectables and biologics manufacturer producing lyophilized products, antisera, and hormonal injectables for hospital and critical care use. Its lyophilization capability and therapeutic-area focus overlap directly with SALSL's portfolio.
• Claris Lifesciences (now Aculife Healthcare): Claris Lifesciences (now Aculife Healthcare) is an Indian sterile injectable manufacturer producing liquid injectables, pre-filled syringes, and lyophilized products for hospital and institutional channels. It is the closest direct comparable to SALSL in product format, regulatory positioning (WHO GMP), and B2B GTM to pharmaceutical companies.

Broad incumbents

• Aurobindo Pharma: Aurobindo Pharma is a large Indian generic manufacturer with a growing sterile injectables business alongside oral solids and APIs. Its injectables franchise competes with SALSL on cost-sensitive molecules and institutional tenders, but within a much broader diversified pharma portfolio.
• Sun Pharmaceutical Industries: Sun Pharma is India's largest pharmaceutical company with a significant sterile injectables portfolio across multiple therapeutic areas including oncology, critical care, and anti-infectives. It is a broader incumbent in the same generic injectable space where SALSL competes, but at vastly greater scale, multi-site footprint, and global commercial reach.
• Dr. Reddy's Laboratories: Dr. Reddy's is a large Indian generic pharmaceutical company with a sterile injectables portfolio in oncology, anti-infectives, and pain management, exporting to regulated markets. It operates as a broad incumbent overlapping with SALSL on molecules such as Enoxaparin and other hospital injectables, but at enterprise scale with biologics, APIs, and biosimilars.
• Cipla: Cipla is a major Indian generic pharmaceutical company with a hospital injectables portfolio across anti-infectives, critical care, and respiratory. It competes with SALSL in the same domestic institutional injectable channels and exports globally, but as part of a much broader branded and generics franchise.

Regional players

• Alpa Laboratories: Alpa Laboratories is a smaller Indian manufacturer producing sterile injectables including small-volume parenterals, lyophilized products, and dry powder injections for domestic and export markets. Its scale and SVP product focus make it a closely comparable India-based peer with similar export orientation.

Market position

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/salsl
• Facebookfacebook.com/Shree-Anand-Life-Sciences-Limited-100054196464114

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shree Anand Life Sciences